BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Marco M, Grassi E, Durante S, Vecchiarelli S, Palloni A, Macchini M, Casadei R, Ricci C, Panzacchi R, Santini D, Biasco G. State of the art biological therapies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(1): 55-66 [PMID: 26798437 DOI: 10.4251/wjgo.v8.i1.55]
URL: https://www.wjgnet.com/1007-9327/full/v8/i1/55.htm
Number Citing Articles
1
Hadas Gibori, Shay Eliyahu, Adva Krivitsky, Dikla Ben-Shushan, Yana Epshtein, Galia Tiram, Rachel Blau, Paula Ofek, Joo Sang Lee, Eytan Ruppin, Limor Landsman, Iris Barshack, Talia Golan, Emmanuelle Merquiol, Galia Blum, Ronit Satchi-Fainaro. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancerNature Communications 2018; 9(1) doi: 10.1038/s41467-017-02283-9
2
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinomaCritical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015
3
Xinjian Liu, Hao Yuan, Jing Zhou, Qiongling Wang, Xiaoqiang Qi, Catharine Bernal, Diego Avella, Jussuf T. Kaifi, Eric T. Kimchi, Parrett Timothy, Kun Cheng, Yi Miao, Kuirong Jiang, Guangfu Li. LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and MetastasisFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.647387
4
M. Bupathi, D. H. Ahn, C. Wu, K. K. Ciombor, J. A. Stephens, J. Reardon, D. A. Goldstein, T. Bekaii-Saab. Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experienceMedical Oncology 2016; 33(4) doi: 10.1007/s12032-016-0753-9
5
Guo Chen, Haiyang Song, Zelong Yang, Tianshu Du, Yu Zheng, Zifan Lu, Kunpeng Zhang, Di Wei. AQP5 Is a Novel Prognostic Biomarker in Pancreatic AdenocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890193
6
Matineh Barati Bagherabad, Fahimeh Afzaljavan, Soodabeh ShahidSales, Seyed Mahdi Hassanian, Amir Avan. Targeted therapies in pancreatic cancer: Promises and failuresJournal of Cellular Biochemistry 2019; 120(3): 2726 doi: 10.1002/jcb.26284
7
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 3421 doi: 10.1007/978-3-662-46875-3_4358
8
Douglas K. Brubaker, Joao A. Paulo, Shikha Sheth, Emily J. Poulin, Olesja Popow, Brian A. Joughin, Samantha Dale Strasser, Alina Starchenko, Steven P. Gygi, Douglas A. Lauffenburger, Kevin M. Haigis. Proteogenomic Network Analysis of Context-Specific KRAS Signaling in Mouse-to-Human Cross-Species TranslationCell Systems 2019; 9(3): 258 doi: 10.1016/j.cels.2019.07.006
9
Catherine S. Wegner, Anette Hauge, Jon-Vidar Gaustad, Lise Mari K. Andersen, Trude G. Simonsen, Kanthi Galappathi, Einar K. Rofstad. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenograftsActa Oncologica 2017; 56(12): 1754 doi: 10.1080/0284186X.2017.1343494
10
Eileen M. O’Reilly, Do-Youn Oh, Neesha Dhani, Daniel J. Renouf, Myung Ah Lee, Weijing Sun, George Fisher, Aram Hezel, Shao-Chun Chang, Gordana Vlahovic, Osamu Takahashi, Yin Yang, David Fitts, Philip Agop Philip. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal AdenocarcinomaJAMA Oncology 2019; 5(10): 1431 doi: 10.1001/jamaoncol.2019.1588
11
Omer Hanif, Zhu Donghua, Wang Xuefeng, M. Saqib Nawaz. Refining the Measurement of Topic Similarities Through Bibliographic Coupling and LDAIEEE Access 2019; 7: 179997 doi: 10.1109/ACCESS.2019.2958489
12
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Henriette Bunge, Caroline Maier, Orkhan Isayev, Florian Neff, Jens T. Siveke, Svetlana Karakhanova. Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancerOncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2043037
13
Giuseppe Tridente. Adverse Events and Oncotargeted Kinase Inhibitors2017; : 145 doi: 10.1016/B978-0-12-809400-6.00007-X
14
Radim Moravec, Rao Divi, Mukesh Verma. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progressionWorld Journal of Gastrointestinal Oncology 2017; 9(6): 235-250 doi: 10.4251/wjgo.v9.i6.235
15
Indraneil Mukherjee, Brett Powell, Mary Parianos, Darrell Downs, Sharona B. Ross. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancerCancer Genetics 2016; 209(12): 582 doi: 10.1016/j.cancergen.2016.08.001
16
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in ProteomicsCancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
17
Giulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, Stefania Cannone, Ilaria Dando, Elisa Dalla Pozza, Maria Mastrodonato, Stefania Forciniti, Valeria Casavola, Marta Palmieri, Stephan Joel Reshkin, Rosa Angela Cardone. Extracellular matrix composition modulatesPDACparenchymal and stem cell plasticity and behavior through the secretomeThe FEBS Journal 2018; 285(11): 2104 doi: 10.1111/febs.14471
18
JINGMEI LUO, LI YU, GUANGCHENG XIE, DAN LI, MENG SU, XUERONG ZHAO, LUANYING DU. Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae ESPsParasitology 2017; 144(6): 793 doi: 10.1017/S0031182016002535
19
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 1 doi: 10.1007/978-3-642-27841-9_4358-4
20
Zilong Zhang, Jin Shang, Zonglin Dai, Yutong Yao, Ying Shi, Deyuan Zhong, Yuxin Liang, Chunyou Lai, Qinyan Yang, Tianhang Feng, Xiaolun Huang. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic AdenocarcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.848391
21
Yong An, Xue-min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-lin Sun, Hui-hua Cai. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancerCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0643-7